Influence of phytotherapy on metabolic status and urine microbiota in patients with urolithiasis — calcium oxalate nephrolithiasis after shock wave lithotripsy
Journal Title: Нирки - Year 2019, Vol 8, Issue 3
Abstract
Background. The study of the problem of urolithiasis in recent years has reached a qualitatively new level in connection with the use of a multidisciplinary approach and the principles of evidence-based medicine. In the domestic literature, there are isolated reports on the meaning and methods of correction of metabolic disorders in urolithiasis. There is still no consensus on the feasibility and effectiveness of preventive methods after the removal of stones. The purpose of the study: assessment of the effect of phytotherapy (Urolesan®) on the metabolic status and urine microbiota in patients with urolithiasis — calcium oxalate nephrolithiasis after shock wave lithotripsy. Materials and methods. In 50 patients with calcium oxalate nephrolithiasis aged 18 to 65 (middle age — 41.1 ± 1.6) years, the effect of Urolesan® on the metabolic status (the impact on urine pH, the level of oxalate, calcium, uric acid excretion, indicators of biochemical blood tests), features of urine microbiota and prevention of the recurrent formation of calculi were studied after shock-wave lithotripsy. Results. An analysis of the dynamics of urine pH, measured on days 2, 5, 10, 20, and 30 of treatment with Urolesan®, showed that the patients undergoing a follow-up examination had a gradual increase in urine pH from 5.80 ± 0.04 to 6.13 ± 0.04 on day 5 (p < 0.05) and up to 6.47 ± 0.04 — on day 30 (p < 0.05). The dynamics of oxalate and calcium urine excretion showed that after a month of treatment with Urolesan®, the daily excretion of oxalate decreased by 1.5 times, and calcium — by 1.2 times compared with baseline (p < 0.05). A positive dynamics is reflected in the indicators of uric acid metabolism. The level of uric acid in blood serum decreased from 397.98 ± 9.48 μmol/l to 339.59 ± 7.64 μmol/l, and in urine — from 4.94 ± 0.15 mmol/l to 4.03 ± 0.08 mmol/l (by 1.2 times) (p < 0.05). After a month of treatment with Urolesan®, bacteriuria was detected in 2 patients during a control bacteriological examination of urine. The results of the study demonstrated the metaphylactic potential of Urolesan® — none of the patients after 6 months of follow-up had recurrent calculus formation. Conclusions. Urolesan® has a positive effect on the metabolic status of patients with urolithiasis — calcium oxalate nephrolithiasis after shock-wave lithotripsy (it normalizes urine pH, reduces oxalate excretion by 1.5 times, calcium and uric acid — by 1.2 times, maintains and improves indicators of biochemical blood tests); eliminates the violation of urine microbiota, reduces the number of patients with bacteriuria; realizes metaphylactic potential, preventing the recurrent formation of stones.
Authors and Affiliations
O. O. Shevchuk, S. V. Kushnirenko, S. O. Vozianov, O. V. Kushnirenko
Keywords
Related Articles
- EP ID EP630017
- DOI -
- Views 80
- Downloads 0
Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
No abstract
Diagnostic role of radionuclide methods in patients with pyelonephritis
Acute and chronic forms of pyelonephritis are the most common diseases of the urinary system in all age groups. The incidence rate of acute pyelonephritis in children is 19.1 per 1000, chronic pyelonephritis — 5–12.5 per...
Renoprotection and its association with eGFR and renal functional reserve
Renoprotection is a system of measures for primarily pharmacological control, contributing to the continued preservation of renal function. When choosing renoprotection tactics, it is necessary to consider not only the e...
2016 European Guidelines on cardiovascular disease prevention in clinical practice
.
The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with volume overload. The goal of therapy in those patients is the relief of congestion through achieving...